Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin

BACKGROUND: Ifosfamide has recently used as the intravenous component of bidirectional intraoperative chemotherapy (BDIC) with hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin. Little is known about the systemic toxicities of this BDIC regimen. Therefore, this study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pleura Peritoneum
Autors principals: Hakeam, Hakeam, Ayman, Azzam, Waleed, Al Taweel, Amen, Tarek
Format: Artigo
Idioma:Inglês
Publicat: De Gruyter 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6881663/
https://ncbi.nlm.nih.gov/pubmed/31799375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2019-0025
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars